Infliximab-induced lupus erythematosus in a case of ulcerative colitis

Infliximab is widely used in the treatment of inflammatory bowel disease, but despite its good clinical efficacy and tolerance, drug-induced autoimmune disorders have been reported as adverse reactions and are a matter of concern. Here we report a patient with ulcerative colitis who developed drug-i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nippon Shokakibyo Gakkai Zasshi 2011, Vol.108(9), pp.1535-1539
Hauptverfasser:	NISHIKAWA, Jun, MIYAZAKI, Takako, SUZUKI, Nobuhiro, ITAYA, Yuko, YAMAWAKI, Hidemoto, MIHARA, Hiroshi, HASUMOTO, Yushi, FUJINAMI, Haruka, OGAWA, Kohei, HOSOKAWA, Ayumu, KUDO, Takahiko, SUGIYAMA, Toshiro
Format:	Artikel
Sprache:	jpn
Schlagworte:	Adult Anti-Inflammatory Agents - adverse effects Antibodies, Monoclonal - adverse effects Colitis, Ulcerative - drug therapy Female Humans Infliximab Lupus Erythematosus, Systemic - chemically induced
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!